ROLE OF LIPOSOME IN NOVEL DRUG DELIVERY SYSTEM
LiposomeÂ was found by Alec Bangham of Babraham Institute in Cambridge, England in 1965.In 1990; drugs with liposome and Amphotericin B were approved by Ireland. In 1995 America F.D.A approved liposor doxodubicin. In 1965s, it was well recognized that microscopic lipid vesicles, known as liposomes, could be utilized to encapsulate drugs and dyes for the purpose of systemic administration and drug targeting.ConsiderableÂ progress was made in 1980s, in engeneering liposomes to circulate longer in blood and remain intact while doing so. The liposome a microscopic spherical particle formed by a lipid bilayer enclosing an aqueous compartment.An artificial microscopic vesicle consisting of an aqueous core enclosed in one or more phospholipid layers, used to convey vaccines, drugs, enzymes, or other substances to target cells or organs. Liposome was discovered about 40 years ago by Bangham and coworkersand was defined as microscopic spherical vesicles that form when phospholipids are hydrated or exposed to anaqueous environment.Liposomes are microscopic vesicles composed of a bilayer of phospholipids or any similar amphipathic lipids. They can encapsulate and effectively deliver both hydrophilic and lipophilic substances2â€3 and may be used as a nonâ€toxic vehicle for insoluble drugs. Liposomes are composed of small vesicles of phospholipids encapsulating an aqueous space ranging from about 0.03 to 10 Âµm in diameter. The membrane of liposome is made of phospholipids, which have phosphoric acid sides to form the liposome bilayers.Liposomes can be manufacturing in different lipid comopsitions or by different method show variation in par. Size , size distribution, surface electrical potential, no. of lamella, encapsulation efficacy,Surface modification showed great advantage to produce liposomes of different mechanisims, kinetic properties and biodistribution
Authors who publish with this journal agree to the following terms:
- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution-NonCommercial 3.0 Unported License. that allows others to share the work with an acknowledgment of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgment of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).